XML 32 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Accounting Policies [Abstract]        
Research and Development Expense $ 16,669 $ 112,610 $ 157,876 $ 323,052
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount     730,366,968 673,692,795
Depreciation $ 5,465 $ 5,465 $ 16,395 $ 16,395